Literature DB >> 8692049

Gene competition and the possible evolutionary role of tumours.

A P Kozlov1.   

Abstract

The evolutionary role of tumours might consist of providing the conditions for the expression of evolutionary new genes and thus in providing the material for the origin of new cell types. To approach this concept the principle of gene competition is essential. With an increase in gene number in the genomes of the evolving multicellular organisms the enforcement of gene competition should take place. Therefore, the pre-existing cell types possess limited possibilities for the expression of evolutionary new genes. Like evolutionary new genes originated from extra copies (duplicates) of old genes, evolutionary new cell types had to originate from extra cells which were not functionally necessary to the organism. Tumours could have supplied the evolving multicellular organisms with extra cells for the expression of originating evolutionary new genes. Of course, on the basis of this proposal only tumours at the earlier stages of progression are considered to be meaningful, or some kind of tumour-like processes, but not malignant tumours at late stages of progression. The evolutionary new genes originate in the DNA of germ line cells but not in DNA of tumour cells. Until the moment of their expression in the tumour cells these genes could stay silent. After the expression of these genes tumour cells should acquire the function in the organism, differentiate and lose their previous autonomy. The organisms with a new cell type should then be selected against their fitness and competitive abilities.

Entities:  

Mesh:

Year:  1996        PMID: 8692049     DOI: 10.1016/s0306-9877(96)90005-5

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  8 in total

1.  PBOV1 is a human de novo gene with tumor-specific expression that is associated with a positive clinical outcome of cancer.

Authors:  Nikolay Samusik; Larisa Krukovskaya; Irina Meln; Evgeny Shilov; Andrey P Kozlov
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

2.  Cancer: evolutionary, genetic and epigenetic aspects.

Authors:  Anatoly V Lichtenstein
Journal:  Clin Epigenetics       Date:  2010-09-14       Impact factor: 6.551

3.  Evolutionarily new sequences expressed in tumors.

Authors:  Andrei P Kozlov; Yuri P Galachyants; Ilya V Dukhovlinov; Nickolai A Samusik; Ancha V Baranova; Dmitry E Polev; Larisa L Krukovskaya
Journal:  Infect Agent Cancer       Date:  2006-12-25       Impact factor: 2.965

4.  Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions.

Authors:  O Adighibe; K Micklem; L Campo; M Ferguson; A Harris; R Pozos; K Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

Review 5.  Expression of evolutionarily novel genes in tumors.

Authors:  A P Kozlov
Journal:  Infect Agent Cancer       Date:  2016-07-19       Impact factor: 2.965

Review 6.  Mammalian tumor-like organs. 1. The role of tumor-like normal organs and atypical tumor organs in the evolution of development (carcino-evo-devo).

Authors:  A P Kozlov
Journal:  Infect Agent Cancer       Date:  2022-01-10       Impact factor: 2.965

7.  Evolutionarily novel genes are expressed in transgenic fish tumors and their orthologs are involved in development of progressive traits in humans.

Authors:  E A Matyunina; A V Emelyanov; T V Kurbatova; A A Makashov; I V Mizgirev; A P Kozlov
Journal:  Infect Agent Cancer       Date:  2019-12-05       Impact factor: 2.965

8.  Oncogenes, tumor suppressor and differentiation genes represent the oldest human gene classes and evolve concurrently.

Authors:  A A Makashov; S V Malov; A P Kozlov
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.